作者
Marc Mendelson, Adrian Brink, Joey Gouws, Nontombi Mbelle, Vinny Naidoo, Troy Pople, Natalie Schellack, Moritz van Vuuren, Helen Rees, Shabir Banoo, Khotso Bokaba, Marius Collins, Kim Faure, Maryke Herbst, Beyers Hoek, Ruth Lancaster, Jeanette Lotter, Mike Modisane, Mahlodi Mohlala, Ernest Mokantla, Adelaide Molatuli, Margaret Molefe, Griffith Molewa, Kefiloe Mompati, Lesiba Moshiga, Shyamli Munbodh, Portia Nkambule, Camilla Patterson, Darshana Reddy, Alice Sigobondhla, Suraiya Suliman, Gerry Swan
发表日期
2018/9/1
期刊
The Lancet Infectious Diseases
卷号
18
期号
9
页码范围
e288-e294
出版商
Elsevier
简介
Increasing reliance on antibiotics of last resort to treat the rising numbers of multidrug-resistant bacterial infections in people has focused attention on how shared-use antibiotics are managed and regulated across human and animal health. Discussions at international and national levels have intensified since the identification of new plasmid-mediated genes for colistin resistance in 2016, first in China and subsequently in many other countries, removing the last line of defense against multidrug-resistant Gram-negative bacterial infections with carbapenem resistance. South Africa has reacted to this threat by doing a situational analysis and review of the existing legislation concerning colistin use in animals and people, to inform which course of action to take. The experiences shared in this Personal View outline the process, institution of governance with widespread stakeholder engagement, surveillance, and …
学术搜索中的文章
M Mendelson, A Brink, J Gouws, N Mbelle, V Naidoo… - The Lancet Infectious Diseases, 2018